Is this you? Create Your Porfile
Avatar

Susan E. Hahn

Hoffmann-La Roche

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Susan E. Hahn is active.

Explore More

Publication

Featured researches published by Susan E. Hahn.

Archive | 2008

Cancerous disease modifying antibodies

David S. F. Young; Susan E. Hahn; Lisa M. Cechetto

Archive | 2007

Cytotoxicity mediation of cells evidencing surface expression of MCSP

David S. F. Young; Susan E. Hahn; Helen P. Findlay; Alison L. Ferry

Archive | 2007

Cancerous disease modifying antibody 141205-05

David S. F. Young; Helen P. Findlay; Susan E. Hahn; Luis A. G. Dacruz; Alison L. Ferry

Archive | 2008

HUMANIZED AND CHIMERIC ANTI-TROP-2 ANTIBODIES THAT MEDIATE CANCER CELL CYTOTOXICITY

David S. F. Young; Helen P. Findlay; Susan E. Hahn; Cruz Luis A. G. Da; Alison L. Ferry

Archive | 2008

Chimeric and humanized anti-cd44 antibodies that mediate cancer cell cytotoxicity

David S. F. Young; Helen P. Findlay; Susan E. Hahn; Lisa M. Cechetto; Fortunata Mcconkey

Cancer Research | 2005

Three unique antibodies demonstrate therapeutic effects against CD63, a novel target for cancer therapy

Susan E. Hahn; Victor Saldivia; Daad Sayegh; Huma Ahmad; Lisa M. Cechetto; Luis da Cruz; D.S. Young

Archive | 2003

Cytotoxicity mediation of cells evidencing surface expression of gp96 or precursors thereof

David S. F. Young; Miyoko Takahashi; Susan E. Hahn

Cancer Research | 2006

AR53A10.11 and AR58A314.1, 2 ARIUS functional monoclonal antibodies target tumor specific antigens

Daad Sayegh; Mitra Amoozgar; Fortunata McConkey; Nives Ceric; Susan E. Hahn; Helen P. Findlay; David S. Young

Archive | 2008

Cancer disease modifying antibody 010207-01 produced by hybridoma cell line ar51a630.3.

David S. F. Young; Helen P. Findlay; Susan E. Hahn; Lisa M. Cechetto

Archive | 2007

Cancerous disease modifying antibodies for diagnostic and therapeutic use in breast and prostate cancer

David S. F. Young; Susan E. Hahn; Helen P. Findlay

Explore More

Collaboration

Dive into the Susan E. Hahn's collaboration.

Top Co-Authors
Avatar

David S. F. Young

OSI Pharmaceuticals

View shared research outputs
Top Co-Authors
Avatar

Helen P. Findlay

Ipsen

View shared research outputs
Top Co-Authors
Avatar

Lisa M. Cechetto

Hoffmann-La Roche

View shared research outputs
Top Co-Authors
Avatar

Alison L. Ferry

Hoffmann-La Roche

View shared research outputs
Top Co-Authors
Avatar

D.S. Young

University of Hong Kong

View shared research outputs
Top Co-Authors
Avatar

Fortunata McConkey

Ipsen

View shared research outputs
Top Co-Authors
Avatar

Cruz Luis A. G. Da

Hoffmann-La Roche

View shared research outputs
Top Co-Authors
Avatar

Helen P. Findlay

Ipsen

View shared research outputs
Top Co-Authors
Avatar

Daad Sayegh

University of Hong Kong

View shared research outputs
Top Co-Authors
Avatar

David S. Young

Ipsen

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge